PAREXEL and Microsoft Form Alliance Aimed at Accelerating the Pace of Drug Development

Published on: 

Applied Clinical Trials

PAREXEL International Corp. and Microsoft Corp. have announced a technology development alliance that plans to help the industry accelerate drug development and provide faster therapies to patients. By combing each companies' expertise and capabilities, this new collbaoration will drive innovation across the life sciences industry.

Read the full release here.